Evidence map›Paper›PMID 37845436›Full record

ReviewAdvances in experimental medicine and biology2023

Pro-survival Phenotype of HIF-1α: Neuroprotection Through Inflammatory Mechanisms.

Michelle A Puchowicz, Kehkashan Parveen, Aarti Sethuraman, Tauheed Ishrat, Kui Xu, Joseph LaManna

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michelle A PuchowiczDepartment of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA. mpuchowi@uthsc.edu.
Kehkashan ParveenDepartment of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.
Aarti SethuramanDepartment of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.
Tauheed IshratDepartment of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN, USA.
Kui XuDepartment of Physiology & Biophysics, Case Western Reserve University, Cleveland, OH, USA.
Joseph LaMannaDepartment of Physiology & Biophysics, Case Western Reserve University, Cleveland, OH, USA.
University of Tennessee Health Science Center · USCase Western Reserve University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia-inducible factor 1 (HIF-1) is a major player in the oxygen sensor system as well as a transcription factor. HIF-1 is also associated in the pathogenesis of many brain diseases including Alzheimer's disease (AD), epilepsy and stroke. HIF-1 regulates the expression of many genes such as those involved in glycolysis, erythropoiesis, angiogenesis and proliferation in hypoxic condition. Despite several studies, the mechanism through which HIF-1 confers neuroprotection remains unclear, one of them is modulating metabolic profiles and inflammatory pathways. Characterization of the neuroprotective role of HIF-1 may be through its stabilization and the regulation of target genes that aid in the early adaptation to the oxidative stressors. It is interesting to note that mounting data from recent years point to an additional crucial regulatory role for hypoxia-inducible factors (HIFs) in inflammation. HIFs in immune cells regulate the production of glycolytic energy as well as innate immunity, pro-inflammatory gene expression, and mediates activation of pro-survival pathways. The present review highlights the contribution of HIF-1 to neuroprotection where inflammation is the crucial factor in the pathogenesis contributing to neural death. The potential mechanisms that contribute to neuroprotection as a result of the downstream targets of HIF-1α are discussed. Such mechanisms include those mediated through IL-10, an anti-inflammatory molecule involved in activating pro-survival signaling mechanisms via AKT/ERK and JAK/STAT pathways.

Indexed as

Gene Expression RegulationNeuroprotectionHumansHypoxia-Inducible Factor 1, alpha SubunitInflammationPhenotypeSignal TransductionHypoxia-Inducible Factor 1, alpha SubunitHIF-1αNeuroinflammationNeuroprotection

Identifiers

PMID37845436
OpenAlexW4387681764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.